Published in Eur J Pediatr on September 21, 2015
Obtaining accurate measurement of carotid intima-media thickness in children with classic congenital adrenal hyperplasia. Eur J Pediatr (2015) 1.06
Left ventricular dysfunction and subclinical atherosclerosis in children with classic congenital adrenal hyperplasia: a single-center study from Upper Egypt. Eur J Pediatr (2015) 0.76
Assessment of cardiac function in children with congenital adrenal hyperplasia: a case control study in Cameroon. BMC Pediatr (2017) 0.75
The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation (1978) 20.37
Variations in the pattern of pubertal changes in boys. Arch Dis Child (1970) 16.22
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet (1992) 11.50
Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 7.70
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 3.80
Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood (1999) 2.79
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med (2013) 2.65
Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest (2000) 2.01
Report of the task force on blood pressure control in children. Pediatrics (1977) 1.60
Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. J Thromb Haemost (2006) 1.49
Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation (1998) 1.47
Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) (2013) 1.46
Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics (2006) 1.33
Management of the child with congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab (2009) 1.30
Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab (2002) 1.22
Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol (2000) 1.15
Low testosterone levels are associated with coronary artery disease in male patients with angina. Int J Impot Res (2006) 1.13
Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol (1994) 1.02
Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clin Endocrinol (Oxf) (2003) 0.99
Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia? Clin Endocrinol (Oxf) (2009) 0.97
Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol (2001) 0.97
Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol (1990) 0.97
Does leptin cause vascular disease? Circulation (2002) 0.96
A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc Res (2002) 0.95
Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs. Eur J Clin Invest (1994) 0.92
Androgen-induced enhancement of vascular reactivity. Can J Physiol Pharmacol (1974) 0.82
Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia. J Clin Endocrinol Metab (2014) 0.82
Increased large artery intima media thickness in adolescents with either classical or non-classical congenital adrenal hyperplasia. J Endocrinol Invest (2011) 0.81
Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Endocrinol (Paris) (2007) 0.81
Comparison of Doppler echocardiographic and hemodynamic indexes of left ventricular diastolic properties in coronary artery disease. Am J Cardiol (1988) 0.79
Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia. J Endocrinol Invest (2014) 0.78
Pathologic remodeling of the myocardium in a weightlifter taking anabolic steroids. Blood Press (1993) 0.78
Blood Pressure and Left Ventricular Characteristics in Young Patients with Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol (2010) 0.77
Androgen deficiency and hormone-replacement therapy. BJU Int (2005) 0.77
Preventive practices for adult cardiovascular disease in children. J Fam Pract (1991) 0.77
Testosterone and atherosclerosis progression in men. Diabetes Care (2003) 0.76
Childhood-onset congenital adrenal hyperplasia: long-term outcome and optimization of therapy. J Pediatr Endocrinol Metab (2004) 0.75